We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
The ASX200 closed +0.5% higher on Tuesday on the back of a big lift in the Mining sector. Lithium s...
Read ArticleThe ASX200 closed up slightly by +0.1% on Monday as gains in tech and gold stocks were offset by los...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleThis week’s Bulls N’ Bears ASX Runner of the Week is… Regeneus Ltd. Its share price surged 220 per c...
Read ArticleAustralian regenerative medicine firm Regeneus (ASX: RGS) and US-headquartered Cambium Medical Techn...
Read ArticleLocal markets give up early gains then regains them, closing 0.22pc higher Consumer Discretionary...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleASX200 ends 0.75pc lower after a long slog back from -1.5pc this morning. Industrial Sector only g...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleThe ASX benchmark has closed slightly higher on Monday Energy Sector gains after oil prices rose ov...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleThe S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% f...
Read ArticleBenchmark ASX crawls back to close +0.12% in the green Seven Sectors close higher, led by REITs and...
Read ArticleBenchmark ASX index closes at new 12-month lows Energy and Materials the worst of 9 dipping ASX sec...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleStockhead’s Top 10 at shortly-before-11-ish, produced with gritted teeth as, once again, the local c...
Read ArticleBenchmark index finds some rare greenage, up 0.5% Property and IT Sectors lead broad-based gains,...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleBenchmark index falls on Monday, closing out the day down 0.21% Utilities and Materials sectors ed...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleBenchmark index settles almost -0.6% lower on Tuesday All sectors bar Healthcare and Financials in...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleLocal markets have pedalled furiously since lunch to bring the benchmark to +0.35%. CBA posts recor...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleThe ASX 200 had another fine day, ending with a 0.73% gain overall Sectors wise, Tech and Real Esta...
Read ArticleThe ASX 200 started poorly, got worse, and only picked up marginally in the arvo (-0.15%) Sectors w...
Read ArticleFortescue Metals Group (FMG) has traded up 1 per cent despite news that founder Andrew Forrest and h...
Read ArticleThe ASX 200 finishes up 1.56% The ASX XEC rises 1.52% All 11 sectors were higher lead by Real Est...
Read ArticleThe S&P ASX 200 closes 1.69% lower setting new 50-day low, with Emerging Companies index also f...
Read ArticleS&P/ASX 200 closes well in the red today: -1.24% after US stocks dipped on the back of Fed hawk...
Read ArticleS&P/ASX 200 closes in the red today: -0.35%, as US stock markets enjoy a July 4 chilli dog, or...
Read ArticleThe S&P ASX 200 was up 1.76% in June, with large caps performing the best and small caps laggin...
Read ArticleAussie markets are down 0.6% after the gubbermint dropped an unpopular look at the future. Gold sto...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleThe ASX 200 climbed 0.86% today, after the RBA said it wants you all to get fired. Energy stocks cl...
Read ArticleLocal markets shook off a post-long-weekend wobble to end the day higher, up 0.23% It’s been anothe...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticlePfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read ArticleASX falls 0.17% ahead of Chalmers dropping The Budget on the nation Financials led the pack today,...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleASX closes 5 points lower, down 0.08% after a day of ups and downs Goldies are the clear winners ag...
Read ArticleASX 200 benchmark closes 0.11% lower after a fickle day on the bourse Iron ore price drops to five...
Read ArticleThe ASX 200 fell 0.21% and the ASX XEC slips 1.05% A 8 out of 11 sectors were lower led by Consumer...
Read ArticleRBA lifts rates 25 basis points, says there’s more where that came from ASX immediately sags 0.5% o...
Read ArticlePsychedelic drugs remain the talk of an otherwise depressed market today Newmont bid for Newcrest h...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleThe S&P ASX 200 rose 7.64%, in its best start to a year ever as global markets rally In a stron...
Read ArticleAussies warned of impending critical chicken meat shortage Data shows food prices rose a staggering...
Read ArticleIMF says Everything’s War on Everything is great, except for the bad bits Short-sighted mortgage ta...
Read ArticleAussie markets expended a lot of energy to go precisely nowhere Guatam Adani left with less than US...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read Article2023 off to a bit of a dismal start, down 1.3% on the opening day of trade GreenX soaring after rum...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleLiterally every sector had a red month, but mining was the worst PayGroup gets surprise $120m takeo...
Read ArticleHighlights The healthcare sector comprises stocks from diversified backgrounds, including health...
Read ArticleEmerging Companies (XEC) index rises on Tuesday, up over 1.2% ASX 200 same, but a wee bit more Lod...
Read ArticleRegenerative medicine company Regeneus (ASX:RGS) has announced that its CEO Karolis Rosickas...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleShareCafeFor a Life Free of Pain By Karolis Rosickas, Regeneus Chief Executive Officer Regenerativ...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleA recent article published in the Advance Science magazine discussed research by Monash University t...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleOn Wednesday the S&P/ASX 200 Index (ASX: XJO) was in fine form and charged to new record high....
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe Australian stock market marginally rose on Friday with S&P/ ASX200 gaining 0.27% to 7080.80...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleThe benchmark index ASX 200 continues its upwards trajectory at the close, after the Reserve Bank of...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleA quick wrap of the ASX’s key winners and losers on Tuesday, August 11. Data is taken after the mark...
Read ArticleClinical-stage regenerative medicine company Regeneus (ASX: RGS) has signed a licence and collaborat...
Read ArticleRegeneus (ASX:RGS) has finally done that deal with Kyocera Corporation to develop and commercialise...
Read ArticleWhile treatments for pain management per se may not receive as much attention as those related to cu...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAustralian regenerative medicine company, Regeneus (ASX: RGS), has announced that Kyocera ha...
Read ArticleA quick wrap of the ASX’s key winners and losers on Wednesday, August 5. Data is taken after the mar...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleOur summary of Regeneus Ltd's recent announcement What's happened? Regeneus Ltd (ASX: RGS, “Regeneus...
Read ArticleSydney-based clinical-stage regenerative medicine company Regeneus (ASX:RGS) has received a...
Read ArticleClinical-stage regenerative medicine company Regeneus Ltd (ASX:RGS) announced on Monday morning that...
Read ArticleSydney-based clinical-stage regenerative medicine company, Regeneus Ltd (ASX:RGS) today received a n...
Read ArticleAs with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time atta...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleClinical stage regenerative medicine company Regeneus Ltd (ASX:RGS) has signed a non-binding memoran...
Read ArticleBiotech company Regeneus (ASX:RGS) is a regenerative medicine company, and the therapy is a novel st...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAsia is rising as a healthcare spender, matching incomes and the long-feared elderly population boom...
Read ArticleDrug development is an extensive process and includes drug discovery & development, pre-clinical...
Read ArticleRegeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, has placed the full shortfal...
Read ArticleDrug Development Process The drug development process starts from drug discovery and ends at the lau...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleRegeneus Limited (ASX: RGS) received a R&D tax incentive of $1.5 million from Australian Tax Off...
Read ArticleInvesting in Small-Cap Stocks Biotech is a dynamic and profitable sector for investors. Capital vent...
Read ArticleOn 15 August 2019, the S&P/ASX 200 Health Care Index is down 2.48% to 34,883, while the benchmar...
Read ArticleCirrus Networks Holdings Limited updated the exchange on its recent contract wins and provided the m...
Read ArticleAustralian clinical-stage regenerative medicine company, Regeneus Ltd (ASX: RGS) recently announced...
Read ArticleSpecial Report: Stem cells still have somewhat of a bad rep, as news headlines either repeat the emb...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
